NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs042240022

Registered date:30/04/2024

Vestibular rehabilitation with nGVS for PPPD

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPersistent postural-perceptual dizziness
Date of first enrollment30/04/2024
Target sample size40
Countries of recruitment
Study typeInterventional
Intervention(s)Control group: Vestibular rehabilitation (VR) under the supervision of a physical therapist (PT) once a week for 30 minutes. Home VR for 15 minutes twice daily. For 8 weeks. Treatment group: Control group treatment + noisy galvanic vestibular stimulation (nGVS) during VR under the supervision of a PT

Outcome(s)

Primary OutcomeChange in DHI scores at pre and 1 months after treatment
Secondary Outcome#total score of DHI #DHI remission rate (14 points or less) and response rate (improvement of 18 points or more) #physical, emotional, functional subscales of DHI #Vertigo Symptom Scale-short form (VSS-sf) #Niigata PPPD Questionnaire (NPQ) #Hospital Anxiety Depression Scale (HADS) #The Patient Global Impression scale (PGI) #Total length of posturography (eye open, eye closed, rubber eye open, rubber eye closed) #TUG Test, Functional Gait Assessment (FGA), Motion Sensitivity Quotient (MSQ) #Visual Analogue Scale about dizziness #Home rehabilitation adherence #adverse events

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 80age old
GenderBoth
Include criteria1.Persistent postural-perceptual dizziness 2.Dizziness Handicap Inventory (DHI) >= 36 3.Hospital Anxiety Depression Scale, subscale of anxiety<=10, subscale of depression<= 10 4.Not planning to change to medications that affect dizziness 5.between the ages of 20 and 80 6. Written informed consent
Exclude criteria1. with metal in the body, such as cerebral artery clips or pacemakers 2. orthopedic conditions (especially acute painful conditions such as fractures, sprains, and separated flesh) 3. with heart disease 4. unable to walk independently 5. malignant tumor 6. pregnancy and immediately after delivery 7. sensory disturbance due to severe peripheral circulatory disturbance caused by diabetes mellitus, etc. 8. skin abnormality (infection, wound, etc.) at the electrode application site, or skin allergy to surface electrodes 9. psychiatric symptoms that are considered uncontrollable even with appropriate treatment such as medication 10. other patients who are judged to be inappropriate as subjects

Related Information

Contact

Public contact
Name Kayoko Kabaya
Address 1,Kawasumi,Mizuho-chou,Mizuho-ku,Nagoya,Aichi Aichi Japan 467-8601
Telephone +81-52-853-8256
E-mail kabaya@med.nagoya-cu.ac.jp
Affiliation Nagoya City University Hospital
Scientific contact
Name Kayoko Kabaya
Address 1,Kawasumi,Mizuho-chou,Mizuho-ku,Nagoya,Aichi Aichi Japan 467-8601
Telephone +81-52-853-8256
E-mail kabaya@med.nagoya-cu.ac.jp
Affiliation Nagoya City University Hospital